| Company Name: |
Biolab Reagents |
| Tel: |
027-65279366 18108604356 |
| Email: |
products@biolabreagent.com |
|
| | Solitomab Basic information |
| Product Name: | Solitomab | | Synonyms: | Solitomab;Research Grade Solitomab (DHD17407);Research Grade Solitomab | | CAS: | 1005198-65-1 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Solitomab Structure]() |
| | Solitomab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Solitomab Usage And Synthesis |
| Uses | Solitomab (AMG 110) is a bispecific anti-CD3 and anti-epithelial-cell-adhesion-molecule (EpCAM) antibody. Solitomab can be used for the research of primary uterine and ovarian carcinosarcoma cancer[1][2]. | | References | [1] Ferrari F, et al. Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro. J Exp Clin Cancer Res. 2015 Oct 17;34:123. DOI:10.1186/s13046-015-0241-7
[2] English DP, et al. Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo. Cancer. 2015 Feb 1;121(3):403-12. DOI:10.1002/cncr.29062 |
| | Solitomab Preparation Products And Raw materials |
|